https://www.selleckchem.com/pr....oducts/tc-s-7009.htm
01-1.05, p less then 0.001) alongside with the whole enterococcal bacteremias trend (IRR 1.02, 95% CIs 1.01-1.04, p = 0.002). A progressive increase in vancomycin-resistant E. faecium (VREfm) bacteremias was observed. Resistance to tigecycline and linezolid was rarely reported. The incidence of enterococcal bloodstream isolates is increasing in Italy, together with the prevalence of VREfm. Resistance to linezolid, a cornerstone drug used in the treatment of VRE bloodstream infection, remains negligible.Introduction Colorectal cancer
Like
Comment
Share